ReFlow Medical, a medical device company based in California, has recently revealed promising initial results of their vascular stent. The stent, called the Wingman Catheter, is designed to help physicians navigate through complex arterial blockages and deliver therapy to the affected area.
The Wingman Catheter is a unique device that combines a guidewire and angioplasty balloon into one tool. This allows physicians to access and treat difficult-to-reach areas of the vasculature with greater precision and control. The device also features a proprietary expandable anchor that helps secure the catheter in place during procedures.
According to ReFlow Medical, the Wingman Catheter has shown impressive results in early clinical trials. In a study of 30 patients with peripheral artery disease (PAD), the device was able to successfully cross the blockage in 97% of cases. Additionally, the device was able to deliver therapy to the affected area in 93% of cases.
These results are particularly significant because PAD is a common and often debilitating condition that affects millions of people worldwide. PAD occurs when there is a buildup of plaque in the arteries that supply blood to the legs and feet. This can cause pain, numbness, and difficulty walking, among other symptoms.
Traditionally, treating PAD has been challenging because the blockages are often located in small, hard-to-reach vessels. However, the Wingman Catheter has shown promise in overcoming these obstacles and delivering effective therapy to the affected area.
ReFlow Medical is currently conducting further clinical trials to gather more data on the safety and efficacy of the Wingman Catheter. The company is also exploring other potential applications for the device, including in the treatment of coronary artery disease (CAD) and chronic total occlusions (CTOs).
Overall, the promising initial results of ReFlow Medical’s vascular stent are an exciting development in the field of interventional cardiology. The Wingman Catheter has the potential to improve outcomes for patients with PAD and other vascular conditions, and could ultimately become a valuable tool for physicians around the world.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- EVM Finance. Unified Interface for Decentralized Finance. Access Here.
- Quantum Media Group. IR/PR Amplified. Access Here.
- PlatoAiStream. Web3 Data Intelligence. Knowledge Amplified. Access Here.
- Source: Plato Data Intelligence.
An Overview of the FDA’s Draft Guidance on Translation of GLP Study Reports in the United States
An Overview of the FDA’s Draft Guidance on Translation of GLP Study Reports in the United States The Food and...